Neumirna Therapeutics secures euro 20M in Series A financing

08/01/2025

Neumirna Therapeutics secures euro 20M in Series A financing Neumirna Therapeutics (‘Neumirna’), an RNA-focused biotech company developing next-generation therapeutics for neurological disorders, is pleased to announce the first closing of its Series A funding round...

A Sunstone team update

01/02/2024

A Sunstone team update After 17 years as General Partner and co-founder of Sunstone Life Science Ventures and almost 40 years in the life science industry, our colleague Sten Verland will be taking on a part-time role as Venture Partner as of February 1. Sten will...

Sunstone Life Science Ventures divests its holding in Arcoma AB

20/12/2023

Sunstone Life Science Ventures divests its holding in Arcoma AB Sunstone announces that one hundred percent of the holding in Arcoma AB have been sold in a structured block sale. Sunstone has been a major owner in Arcoma since 2010 and is proud of what the company has...

IO Biotech, Inc. Announces USD 75 Million Private Placement Financing

09/08/2023

IO Biotech, Inc. Announces USD 75 Million Private Placement Financing IO Biotech, Inc. (Nasdaq: IOBT), a clinical biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, today announced that it has entered...